相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008
R. Phillip Dellinger et al.
CRITICAL CARE MEDICINE (2008)
Linezolid versus glycopeptide or beta-lactam for treatment of Gram-positive bacterial infections: meta-analysis of randomised controlled trials
Matthew E. Falagas et al.
LANCET INFECTIOUS DISEASES (2008)
Optimizing therapy for MRSA pneumonia
Lee P. Skrupky et al.
SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Effects of delayed oxygenation assessment on time to antibiotic delivery and mortality in patients with severe community-acquired pneumonia
Stijn I. Blot et al.
CRITICAL CARE MEDICINE (2007)
Effects of systemic steroids in patients with severe community-acquired pneumonia
C. Garcia-Vidal et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Combination antibiotic therapy improves survival in patients with community-acquired pneumonia and shock
Alejandro Rodriguez et al.
CRITICAL CARE MEDICINE (2007)
Antibiotics for bacteremic pneumonia - Improved outcomes with macrolides but not fluoroquinolones
Mark L. Meterky et al.
CHEST (2007)
Granulocyte-Colony Stimulating Factor (G-CSF) as an adjunct to antibiotics in the treatment of pneumonia in adults
A. C. Cheng et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2007)
Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults
Lionel A. Mandell et al.
CLINICAL INFECTIOUS DISEASES (2007)
Impact of guideline-concordant empiric antibiotic therapy in community-acquired pneumonia
Christopher R. Frei et al.
AMERICAN JOURNAL OF MEDICINE (2006)
Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season
Jeffrey C. Hageman et al.
EMERGING INFECTIOUS DISEASES (2006)
Cortisol levels in patients with severe community-acquired pneumonia
J Salluh et al.
INTENSIVE CARE MEDICINE (2006)
Associated inflammatory response in pneumonia:: role of adjunctive therapy with glucocorticoids
A Rañó et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2006)
Severe sepsis in community-acquired pneumonia - When does it happen, and do systemic inflammatory response syndrome criteria help predict course?
T Dremsizov et al.
CHEST (2006)
Validation of a predictive rule for the management of community-acquired pneumonia
A Capelastegul et al.
EUROPEAN RESPIRATORY JOURNAL (2006)
Antibiotic prescription for community-acquired pneumonia in the intensive care unit:: Impact of adherence to Infectious Diseases Society of America guidelines on survival
M Bodí et al.
CLINICAL INFECTIOUS DISEASES (2005)
Guidelines for the management of adult lower respiratory tract infections
M Woodhead et al.
EUROPEAN RESPIRATORY JOURNAL (2005)
Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death
E Abraham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Empirical atypical coverage for inpatients with community-acquired pneumonia - Systematic review of randomized controlled trials
D Shefet et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Overview of nosocomial infections caused by gram-negative bacilli
R Gaynes et al.
CLINICAL INFECTIOUS DISEASES (2005)
Prognosis factors and outcome of community-acquired pneumonia needing mechanical ventilation
E Tejerina et al.
JOURNAL OF CRITICAL CARE (2005)
Modulation of neutrophil and inflammation markers in chronic obstructive pulmonary disease by short-term azithromycin treatment
MJ Parnham et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
Comparison of levofloxacin and cefotaxime combined with ofloxacin for ICU patients with community-acquired pneumonia who do not require vasopressors
O Leroy et al.
CHEST (2005)
Antimicrobial treatment of lower respiratory tract infections in the hospital setting
RF Grossman et al.
AMERICAN JOURNAL OF MEDICINE (2005)
Ventilator settings as a risk factor for acute respiratory distress syndrome in mechanically ventilated patients
O Gajic et al.
INTENSIVE CARE MEDICINE (2005)
Severe community-acquired pneumonia as a cause of severe sepsis: Data from the PROWESS study
PF Laterre et al.
CRITICAL CARE MEDICINE (2005)
Lower mortality among patients with community-acquired pneumonia treated with a macrolide plus a beta-lactam agent versus a beta-lactam agent alone
EG Vázquez et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2005)
Guidelines for the management, of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia
[Anonymous]
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Clarithromycin co-administered with amikacin attenuates systemic inflammation in experimental sepsis with Escherichia coli
EJ Giamarellos-Bourboulis et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2005)
Hydrocortisone infusion for severe community-acquired pneumonia - A preliminary randomized study
M Confalonieri et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Anti-inflammatory effects of macrolides - an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?
GW Amsden
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes
JS Francis et al.
CLINICAL INFECTIOUS DISEASES (2005)
Validation of predictive rules and indices of severity for community acquired pneumonia
S Ewig et al.
THORAX (2004)
How can clinicians measure safety and quality in acute care?
PJ Pronovost et al.
LANCET (2004)
Timing of antibiotic administration and outcomes for medicare patients hospitalized with community-acquired pneumonia
PM Houck et al.
ARCHIVES OF INTERNAL MEDICINE (2004)
Prospective observational study of bacteremic pneumococcal pneumonia: Effect of discordant therapy on mortality
M Lujan et al.
CRITICAL CARE MEDICINE (2004)
Multicenter, open-label, randomized study to compare the safety and efficacy of levofloxacin versus ceftriaxone sodium and erythromycin followed by clarithromycin and amoxicillin-clavulanate in the treatment of serious community-acquired pneumonia in adults
C Fogarty et al.
CLINICAL INFECTIOUS DISEASES (2004)
Improvement of process-of-care and outcomes after implementing a guideline for the management of community-acquired pneumonia:: A controlled before-and-after design study
A Capelastegui et al.
CLINICAL INFECTIOUS DISEASES (2004)
Ventilator-associated lung injury in patients without acute lung injury at the onset of mechanical ventilation
O Gajic et al.
CRITICAL CARE MEDICINE (2004)
Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia
LM Baddour et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2004)
Validation of the 2001 American Thoracic Society criteria for severe community-acquired pneumonia
PD Riley et al.
CRITICAL CARE MEDICINE (2004)
Macrolide activities beyond their antimicrobial effects: macrolides in diffuse panbronchiolitis and cystic fibrosis
MJ Schultz
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Effects of guideline-concordant antimicrobial therapy on mortality among patients with community-acquired pneumonia
EM Mortensen et al.
AMERICAN JOURNAL OF MEDICINE (2004)
Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia
G Sakoulas et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections
PA Moise-Broder et al.
CLINICAL PHARMACOKINETICS (2004)
Mortality in monotherapy versus combination therapy in severe community-acquired pneumonia: A systematic review
MI Restrepo et al.
CHEST (2003)
Systemic host responses in severe sepsis analyzed by causative microorganism and treatment effects of drotrecogin alfa (activated)
SM Opal et al.
CLINICAL INFECTIOUS DISEASES (2003)
Drotrecogin alfa (activated) in the treatment of severe sepsis patients with multiple-organ dysfunction: Data from the PROWESS trial
JF Dhainaut et al.
INTENSIVE CARE MEDICINE (2003)
Factors associated with death among adults <55 years of age hospitalized for community-acquired pneumonia
TJ Marrie et al.
CLINICAL INFECTIOUS DISEASES (2003)
Addition of a macrolide to a β-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia
JA Martínez et al.
CLINICAL INFECTIOUS DISEASES (2003)
Multicenter, double-blind, placebo-controlled study of the use of filgrastim in patients hospitalized with pneumonia and severe sepsis
RK Root et al.
CRITICAL CARE MEDICINE (2003)
Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults
LA Mandell et al.
CLINICAL INFECTIOUS DISEASES (2003)
Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis
EW Ely et al.
CRITICAL CARE MEDICINE (2003)
Systemic cytokine levels in community-acquired pneumonia and their association with disease severity
G Antunes et al.
EUROPEAN RESPIRATORY JOURNAL (2002)
Community-acquired pneumonia due to gram-negative bacteria and Pseudomonas aeruginosa -: Incidence, risk, and prognosis
F Arancibia et al.
ARCHIVES OF INTERNAL MEDICINE (2002)
Severe community-acquired pneumonia - Use of intensive care services and evaluation of American and British Thoracic Society diagnostic criteria
DC Angus et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
Monitoring antimicrobial use and resistance: Comparison with a national benchmark on reducing vancomycin use and vancomycin-resistant enterococci
SK Fridkin et al.
EMERGING INFECTIOUS DISEASES (2002)
Causes of death for patients with community-acquired pneumonia - Results from the pneumonia patient outcomes research team cohort study
EM Mortensen et al.
ARCHIVES OF INTERNAL MEDICINE (2002)
Transient transgenic expression of gamma interferon promotes Legionella pneumophila clearance in immunocompetent hosts
JC Deng et al.
INFECTION AND IMMUNITY (2001)
Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia
GW Waterer et al.
ARCHIVES OF INTERNAL MEDICINE (2001)
Efficacy of low tidal volume ventilation in patients with different clinical risk factors for acute lung injury and the acute respiratory distress syndrome
MD Eisner et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care
DC Angus et al.
CRITICAL CARE MEDICINE (2001)
Guidelines for the management of adults with community-acquired pneumonia - Diagnosis, assessment of severity, antimicrobial therapy, and prevention
MS Niederman et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
Empiric antibiotic therapy anal mortality among Medicare pneumonia inpatients in 10 western states - 1993, 1995, and 1997
PM Houck et al.
CHEST (2001)
Cost-effectiveness of gatifloxacin vs ceftriaxone with a macrolide for the treatment of community-acquired pneumonia
LD Dresser et al.
CHEST (2001)
Decreased mortality after implementation of a treatment guideline for community-acquired pneumonia
NC Dean et al.
AMERICAN JOURNAL OF MEDICINE (2001)
Efficacy and safety of recombinant human activated protein C for severe sepsis.
GR Bernard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Effects of a practice guideline for community-acquired pneumonia in an outpatient setting
MR Suchyta et al.
AMERICAN JOURNAL OF MEDICINE (2001)
Effectiveness of levofloxacin for adult community-acquired pneumonia caused by macrolide-resistant Streptococcus pneumoniae:: Integrated results from four open-label, multicenter, phase III clinical trials
CM Fogarty et al.
CLINICAL THERAPEUTICS (2001)
Filgrastim in patients with pneumonia and severe sepsis or septic shock
RG Wunderink et al.
CHEST (2001)
Clinical application of a prognostic model for severe community-acquired pneumonia
R Mehta et al.
CHEST (2001)
Advances in the research and development of chemotherapeutic agents for respiratory tract bacterial infections
M Cazzola et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2001)
Pseudomonas aeruginosa community-acquired pneumonia in previously healthy adults:: Case report and review of the literature
TF Hatchette et al.
CLINICAL INFECTIOUS DISEASES (2000)
Community-acquired bacterial pneumonia in human immunodeficiency virus-infected patients -: Validation of severity criteria
E Cordero et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Community-acquired pneumonia -: Etiology, epidemiology, and outcome at a teaching hospital in Argentina
CM Luna et al.
CHEST (2000)
Management of community-acquired pneumonia in the era of pneumococcal resistance -: A report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group
JD Heffelfinger et al.
ARCHIVES OF INTERNAL MEDICINE (2000)
Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome.
RG Brower et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Economic assessment of the community-acquired pneumonia intervention trial employing levofloxacin
CS Palmer et al.
CLINICAL THERAPEUTICS (2000)
Assessment of prognosis in patients with community-acquired pneumonia who require mechanical ventilation
FE Pascual et al.
CHEST (2000)
分享论文
